Skip to main content

Advertisement

Log in

Pictorial essay: imaging findings following Y90 radiation segmentectomy for hepatocellular carcinoma

  • Pictorial essay
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Transarterial radioembolization is a novel therapy that has gained rapid clinical acceptance for the treatment of hepatocellular carcinoma (HCC). Segmental radioembolization [also termed radiation segmentectomy (RS)] is a technique that can deliver high doses (> 190 Gy) of radiation selectively to the hepatic segment(s) containing the tumor. The aim of this comprehensive review is to provide an illustrative summary of the most relevant imaging findings encountered after radiation segmentectomy. A 62-patient cohort of Child–Pugh A patients with solitary HCC < 5 cm in size was identified. A comprehensive retrospective imaging review was done by interventional radiology staff at our institution. Important imaging findings were reported and illustrated in a descriptive account. For the purposes of completeness, specific patients outside our initial cohort with unique educational imaging features that also underwent segmentectomy were included in this pictorial essay. This review shows that response assessment after RS requires a learning curve with common drawbacks that can lead to false-positive interpretations and secondary unnecessary treatments. It is important to recognize that treatment responses and pathological changes both are time dependent. Findings such as benign geographical enhancement and initial benign pathological enhancement can easily be misinterpreted. Capsular retraction and segmental atrophy are some other examples of unique post-RS response that are not seen in any other treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16
Fig. 17
Fig. 18
Fig. 19
Fig. 20

Similar content being viewed by others

References

  1. El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142(6):1264–1273.e1

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mazzaferro V, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693–699

    Article  PubMed  CAS  Google Scholar 

  3. Padia SA, et al. (2017) Segmental Yttrium-90 radioembolization versus segmental chemoembolization for localized hepatocellular carcinoma: results of a single-center, retrospective, propensity score-matched study. J Vasc Interv Radiol. https://doi.org/10.1016/j.jvir.2017.02.018

    Article  PubMed  Google Scholar 

  4. Riaz A, et al. (2011) Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization. Int J Radiat Oncol Biol Phys 79(1):163–171

    Article  PubMed  Google Scholar 

  5. Gaba RC, et al. (2009) Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol 16(6):1587–1596

    Article  PubMed  Google Scholar 

  6. Vouche M, et al. (2014) Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy. Hepatology 60(1):192–201

    Article  PubMed  Google Scholar 

  7. Salem R, Thurston KG (2006) Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol 17(8):1251–1278

    Article  PubMed  Google Scholar 

  8. Nordion M (2004) TheraSphere yttrium-90 microspheres package insert. Kanata: MDS Nordion

    Google Scholar 

  9. Hiatt JR, Gabbay J, Busuttil RW (1994) Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg 220(1):50–52

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Michels NA (1966) Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg 112(3):337–347

    Article  PubMed  CAS  Google Scholar 

  11. Abdelmaksoud MH, et al. (2011) Consolidation of hepatic arterial inflow by embolization of variant hepatic arteries in preparation for yttrium-90 radioembolization. J Vasc Interv Radiol 22(10):1364–1371.e1

    Article  PubMed  Google Scholar 

  12. Karunanithy N, et al. (2011) Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy. Cardiovasc Intervent Radiol 34(2):287–294

    Article  PubMed  Google Scholar 

  13. Campbell AM, Bailey IH, Burton MA (2000) Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 45(4):1023–1033

    Article  PubMed  CAS  Google Scholar 

  14. Lewandowski RJ, et al. (2007) Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 30(4):571–592

    Article  PubMed  Google Scholar 

  15. Louie JD, et al. (2009) Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol 20(5):606–613

    Article  PubMed  Google Scholar 

  16. Becker C, et al. (2011) C-arm computed tomography compared with positron emission tomography/computed tomography for treatment planning before radioembolization. Cardiovasc Intervent Radiol 34(3):550–556

    Article  PubMed  Google Scholar 

  17. Virmani S, et al. (2007) Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors. J Vasc Interv Radiol 18(10):1305–1309

    Article  PubMed  Google Scholar 

  18. Wallace MJ, et al. (2007) Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol 18(12):1500–1507

    Article  PubMed  Google Scholar 

  19. Boas FE, et al. (2015) Optimal imaging surveillance schedules after liver-directed therapy for hepatocellular carcinoma. J Vasc Interv Radiol 26(1):69–73

    Article  PubMed  Google Scholar 

  20. Gaba RC, et al. (2015) Clinical and imaging follow-up practices after transarterial therapy for primary and secondary hepatic malignancies. Acad Radiol 22(12):1510–1515

    Article  PubMed  Google Scholar 

  21. Gaba RC (2012) Chemoembolization practice patterns and technical methods among interventional radiologists: results of an online survey. Am J Roentgenol 198(3):692–699

    Article  Google Scholar 

  22. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022

    Article  PubMed  PubMed Central  Google Scholar 

  23. European Association for Study of Liver; European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908–943

    Article  Google Scholar 

  24. Bruix J, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35(3):421–430

    Article  PubMed  CAS  Google Scholar 

  25. Organization, W.H. (1979) WHO Handbook for Reporting Results of Cancer Treatment. Geneva: WHO

    Google Scholar 

  26. Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30(1):52–60

    Article  PubMed  CAS  Google Scholar 

  27. Memon K, et al. (2011) Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times. Gastroenterology 141(2):526–35, 535.e1–2

  28. Jung ES, et al. (2013) Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. J Hepatol 58(6):1181–1187

    Article  PubMed  Google Scholar 

  29. Gillmore R, et al. (2011) EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. J Hepatol 55(6):1309–1316

    Article  PubMed  Google Scholar 

  30. Kulik LM, et al. (2006) Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94(7):572–586

    Article  PubMed  CAS  Google Scholar 

  31. Sangro B, et al. (2006) Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 66(3):792–800

    Article  PubMed  CAS  Google Scholar 

  32. Salem R, et al. (2005) Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16(12):1627–1639

    Article  PubMed  Google Scholar 

  33. Kulik LM, et al. (2008) Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 47(1):71–81

    Article  PubMed  Google Scholar 

  34. Tirumani SH, et al. (2014) Update on the role of imaging in management of metastatic colorectal cancer. Radiographics 34(7):1908–1928

    Article  PubMed  PubMed Central  Google Scholar 

  35. Keppke AL, et al. (2007) Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres. AJR Am J Roentgenol 188(3):768–775

    Article  PubMed  Google Scholar 

  36. Camacho JC, et al. (2015) (90)Y radioembolization: multimodality imaging pattern approach with angiographic correlation for optimized target therapy delivery. Radiographics 35(5):1602–1618

    Article  PubMed  Google Scholar 

  37. Riaz A, et al. (2009) Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology 49(4):1185–1193

    Article  PubMed  Google Scholar 

  38. Bester L, et al. (2011) Imaging characteristics following 90yttrium microsphere treatment for unresectable liver cancer. J Med Imaging Radiat Oncol 55(2):111–118

    Article  PubMed  Google Scholar 

  39. Atassi B, et al. (2008) Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. Radiographics 28(1):81–99

    Article  PubMed  Google Scholar 

  40. Kallini JR, et al. (2016) Hepatic imaging following intra-arterial embolotherapy. Abdom Radiol (NY) 41(4):600–616

    Article  Google Scholar 

  41. Minocha J, Lewandowski RJ (2015) Assessing imaging response to therapy. Radiol Clin North Am 53(5):1077–1088

    Article  PubMed  Google Scholar 

  42. Ibrahim SM, et al. (2009) Radiologic findings following Y90 radioembolization for primary liver malignancies. Abdom Imaging 34(5):566–581

    Article  PubMed  Google Scholar 

  43. Memon K, et al. (2012) Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis. J Hepatol 56(5):1112–1120

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Study concept and design: Ronald A Mora, Rehan Ali, Ahmed Gabr, Nadine Abouchaleh, Ali Al Asadi, Joseph Ralph Kallini, Ahsun Riaz, Robert J Lewandowski, Riad Salem. Acquisition of data: Ronald A Mora, Rehan Ali, Ahmed Gabr, Nadine Abouchaleh, Ali Al Asadi, Ahsun Riaz, Robert J Lewandowski, Riad Salem. Analysis and interpretation of data: Ronald A Mora, Rehan Ali, Ahmed Gabr, Nadine Abouchaleh, Ali Al Asadi, Ahsun Riaz, Robert J Lewandowski, Riad Salem. Drafting of the manuscript: Ronald A Mora, Rehan Ali, Ahmed Gabr, Nadine Abouchaleh, Ali Al Asadi, Joseph Ralph Kallini, Ahsun Riaz, Robert J Lewandowski, Riad Salem. Critical revision of the manuscript for important intellectual content: All Authors. Statistical analysis: Ronald A Mora, Rehan Ali, Ahmed Gabr, Nadine Abouchaleh, Ali Al Asadi, Ahsun Riaz, Robert J Lewandowski, Riad Salem. Administrative, technical, or material support: Ronald A Mora, Rehan Ali, Ahmed Gabr, Nadine Abouchaleh, Ali Al Asadi, Ahsun Riaz, Robert J Lewandowski, Riad Salem. Study supervision: Ronald A Mora, Rehan Ali, Ahmed Gabr, Nadine Abouchaleh, Ali Al Asadi, Joseph Ralph Kallini, Ahsun Riaz, Robert J Lewandowski, Riad Salem.

Corresponding author

Correspondence to Riad Salem.

Ethics declarations

Conflict of interest

RJL and RS are advisors to BTG. None of the other co-authors report any conflict of interest.

Ethical Compliance

The study was Health Insurance Portability and Accountability Act compliant. All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.

Informed consent was obtained from all individual participants included in the study.

No funding was obtained for this study.

No studies were performed on animal subjects by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mora, R.A., Ali, R., Gabr, A. et al. Pictorial essay: imaging findings following Y90 radiation segmentectomy for hepatocellular carcinoma. Abdom Radiol 43, 1723–1738 (2018). https://doi.org/10.1007/s00261-017-1391-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-017-1391-1

Keywords

Navigation